Record Breaking Fentanyl Bust at US Border Raises Concerns Regarding Drug Screening

  • 0

Record Breaking Fentanyl Bust at US Border Raises Concerns Regarding Drug Screening

On January 31, US Customs and Border Protection made the largest ever bust of Fentanyl, a synthetic opioid that’s estimated to be 50 – 100 times more potent than morphine. Due to Fentanyl’s highly addictive properties as well as the fact that it’s often mistaken for and mixed with its less potent relative, Heroin, the American Medical Association states it is responsible for nearly half of all drug overdose deaths in the US. With that being the case, it may surprise you that Fentanyl and other synthetic opioids are not commonly tested for on a standard Non DOT regulated 10 panel drug screen and thus employers may not be getting the results they need. Click the link below for additional information regarding the drug bust.

http://fortune.com/2019/01/31/fentanyl-mexico-border-bust-opioid-crisis/

The good news for companies is that CRC offers an extended narcotics panel add on to the standard 10 panel drug screen which screens for Fentanyl and other opioids. CRC’s integrated drug screening services allow for company representatives to schedule collections via an easy-to-use paperless platform. Reach out to CRC if you’re a current customer who’d like to update their policy or if you’re an employer who wants to ensure they’re receiving the best service available.